Chen Liu

Title: Chen Liu - Innovator in Analgesic Polypeptides

Introduction

Chen Liu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with analgesic properties. His innovative work aims to address pain management through novel biochemical solutions.

Latest Patents

Chen Liu holds a patent for a polypeptide having analgesic activity. The patent describes a polypeptide with the amino acid sequence of X-X-Cys-Ser-Thr-Pro-Pro-X-X-Val-Leu-Tyr-X (SEQ ID NO: 1), or a pharmaceutically acceptable salt thereof. The polypeptide demonstrates good inhibitory effects on physicochemical irritating pain, as well as pathological and neuropathic pain. It has been shown to significantly increase the pain threshold in mice and prolong their heat tolerance time, while also minimizing adverse reactions such as spontaneous movement and excitability.

Career Highlights

Chen Liu is associated with Nanjing Anji Biological Technology Co., Ltd., where he continues to advance his research in the field of analgesics. His work is characterized by a commitment to improving pain management therapies through innovative biotechnological approaches.

Collaborations

Chen Liu collaborates with Hanmei Xu, contributing to the advancement of their shared research goals in the field of biotechnology.

Conclusion

Chen Liu's contributions to the development of analgesic polypeptides highlight his role as an innovator in biotechnology. His work not only addresses critical pain management issues but also paves the way for future advancements in therapeutic solutions.